Developer docs
API playgroundTry for free, no card

Search company profiles

Physiq

Full company profile

uuid00026v1

Namestring
Physiq
Websiteurl
physiq.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

PhysIQ is a Chicago-based, privately held healthcare technology company founded in 2011 that applies proprietary artificial intelligence to data captured from wearable biosensors to continuously monitor patients. The company positions its platform at the intersection of digital health and clinical decision support, targeting healthcare providers and health systems that require longitudinal physiological insight outside traditional care settings.

The company is led by co-founders Gary Conkright (Chairman and CEO) and Matt Pipke (Chief Digital Health Officer), supported by a dedicated C-suite including a Chief Scientific Officer (Stephan Wegerich) and Chief Operating Officer (Joel Splan), as well as commercial leadership comprising a VP of Marketing and two SVP/GM roles with specific healthcare remit (Gary Manning; John Wilson). The firm has raised approximately $26.4 million in aggregate disclosed funding across six rounds from 2013 through 2020, with investors including 4490 Ventures (lead on the largest $8M round in 2017), LionBird, GF Securities, Quark Venture, Pioneer Healthcare Partners, 20/20 HealthCare Partners, and Purdue Foundry Investment Fund. Headcount is stated at 51–100 employees. Notably, the company's primary website (physiq.com) is currently returning a Cloudflare DNS resolution error, and the most recent disclosed funding activity dates to January 2020, creating material uncertainty about current operational scale and trajectory.

The business model and pricing structure are not publicly disclosed in available sources. Publicly referenced proprietary technology features include novel multiscale modeling architectures and digital twin frameworks; however, several of these detailed technology descriptions reference cancer drug synergy prediction and tumor-immune modeling that appear inconsistent with the wearable biosensor monitoring positioning and likely reflect data cross-attribution rather than first-party PhysIQ technology. What can be confirmed is that the firm's first-party positioning centers on proprietary AI applied to wearable biosensor data streams for continuous patient monitoring, with scientific output evidenced in Nature-indexed publications dated 2024 and 2026.

Short descriptiontext

PhysIQ is a Chicago-based healthcare technology company founded in 2011 that applies proprietary AI to wearable biosensor data to continuously monitor patients for healthcare providers and health systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
remote patient monitoring, wearable biosensor analytics, AI healthcare platform, digital health monitoring, continuous physiological monitoring
Industry5 codes
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAFAG
Medical-Grade Device Connectivity & Device Management (MDM)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLALABAF
Chronic Care & Remote Patient Monitoring (RPM) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Remote Patient Monitoring Software
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Physiq develops and delivers a healthcare technology platform that uses proprietary artificial intelligence together with wearable biosensors to monitor patients, producing continuous physiological data and clinical insights for healthcare providers managing patients outside traditional clinical settings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Simulation results aligned with experimental data for drug combination predictions
Product and service1 record
1PhysIQ AI Biosensor Patient Monitoring Platform
CategoryRemote Patient Monitoring Software
Description

Healthcare technology platform that pairs proprietary AI analytics with wearable biosensors to continuously monitor patients and translate physiological data into clinical insights for healthcare providers.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Preventice, now part of Boston Scientific, offers BodyGuardian wearable cardiac monitors with cloud-based analytics, comparable to PhysIQ's continuous monitoring and AI analytics approach. Both target hospital systems and cardiology practices.

TypeBroad incumbent
Description

Medtronic offers a broad portfolio of patient monitoring, implanted sensors, and remote cardiac devices with integrated analytics. It is comparable as the scaled incumbent that PhysIQ's wearable biosensor platform would compete against for hospital contracts.

TypeBroad incumbent
Description

GE HealthCare provides patient monitoring solutions including wearable and bedside vital signs devices with central monitoring analytics. It is comparable as an established incumbent in clinical-grade continuous monitoring that targets the same hospital customer base as PhysIQ.

TypeBroad incumbent
Description

BioTelemetry, acquired by Philips, provides remote cardiac monitoring services and connected device infrastructure for ambulatory patients. It is comparable as a scaled incumbent in wearable biosensor-driven RPM with hospital-channel reach.

TypeDirect peer
Description

iRhythm develops wearable cardiac monitoring patches (Zio) with AI-based arrhythmia detection, directly comparable to PhysIQ's wearable biosensor patient monitoring platform. Both target continuous ambulatory monitoring with proprietary analytics for clinical decision support.

TypeDirect peer
Description

Vivify Health provides an RPM platform with connected devices and patient engagement tools for chronic care management. It is comparable to PhysIQ in combining wearable/connected biosensors with a software platform for clinical monitoring.

TypeBroad incumbent
Description

Dexcom manufactures continuous glucose monitoring wearable sensors with cloud-based data analytics. It is comparable as a scaled wearable biosensor company with proprietary sensor technology and AI-driven clinical insights.

TypeDirect peer
Description

Current Health offers an FDA-cleared continuous vital signs monitoring platform with a wearable device and AI analytics for hospital-at-home and post-acute care. It directly overlaps with PhysIQ's described wearable biosensor + AI monitoring business.

9Tempus Labs
TypeEmerging player
Description

Tempus builds AI-driven precision medicine platforms integrating clinical and molecular data, including patient digital-twin-adjacent capabilities. It overlaps with PhysIQ's described computational modeling and digital twin work in cancer treatment.

TypeEmerging player
Description

Health Catalyst provides healthcare data and analytics infrastructure, including real-world clinical data platforms for providers and life sciences. It is comparable to PhysIQ's data integration and clinical analytics layer of the business.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Physiq

Remote Patient Monitoring Softwarephysiq.com

PhysIQ is a Chicago-based healthcare technology company founded in 2011 that applies proprietary AI to wearable biosensor data to continuously monitor patients for healthcare providers and health systems.

What Physiq does

PhysIQ is a Chicago-based, privately held healthcare technology company founded in 2011 that applies proprietary artificial intelligence to data captured from wearable biosensors to continuously monitor patients. The company positions its platform at the intersection of digital health and clinical decision support, targeting healthcare providers and health systems that require longitudinal physiological insight outside traditional care settings.

The company is led by co-founders Gary Conkright (Chairman and CEO) and Matt Pipke (Chief Digital Health Officer), supported by a dedicated C-suite including a Chief Scientific Officer (Stephan Wegerich) and Chief Operating Officer (Joel Splan), as well as commercial leadership comprising a VP of Marketing and two SVP/GM roles with specific healthcare remit (Gary Manning; John Wilson). The firm has raised approximately $26.4 million in aggregate disclosed funding across six rounds from 2013 through 2020, with investors including 4490 Ventures (lead on the largest $8M round in 2017), LionBird, GF Securities, Quark Venture, Pioneer Healthcare Partners, 20/20 HealthCare Partners, and Purdue Foundry Investment Fund. Headcount is stated at 51–100 employees. Notably, the company's primary website (physiq.com) is currently returning a Cloudflare DNS resolution error, and the most recent disclosed funding activity dates to January 2020, creating material uncertainty about current operational scale and trajectory.

The business model and pricing structure are not publicly disclosed in available sources. Publicly referenced proprietary technology features include novel multiscale modeling architectures and digital twin frameworks; however, several of these detailed technology descriptions reference cancer drug synergy prediction and tumor-immune modeling that appear inconsistent with the wearable biosensor monitoring positioning and likely reflect data cross-attribution rather than first-party PhysIQ technology. What can be confirmed is that the firm's first-party positioning centers on proprietary AI applied to wearable biosensor data streams for continuous patient monitoring, with scientific output evidenced in Nature-indexed publications dated 2024 and 2026.

Physiq firmographics

Firmographics
Name
Physiq
Website
https://physiq.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
PhysIQ is a Chicago-based healthcare technology company founded in 2011 that applies proprietary AI to wearable biosensor data to continuously monitor patients for healthcare providers and health systems.
Ownership category
akta.pro rank

Physiq industry classification

Industry
Product category
Remote Patient Monitoring Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAFAG
Medical-Grade Device Connectivity & Device Management (MDM)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLALABAF
Chronic Care & Remote Patient Monitoring (RPM) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Remote patient monitoring
  • Wearable biosensor analytics
  • AI healthcare platform
  • Digital health monitoring
  • Continuous physiological monitoring

Where Physiq is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Markets served

Physiq business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Physiq product offering

Product offering

Core offering

Physiq develops and delivers a healthcare technology platform that uses proprietary artificial intelligence together with wearable biosensors to monitor patients, producing continuous physiological data and clinical insights for healthcare providers managing patients outside traditional clinical settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • PhysIQ AI Biosensor Patient Monitoring Platform Healthcare technology platform that pairs proprietary AI analytics with wearable biosensors to continuously monitor patients and translate physiological data into clinical insights for healthcare providers.

Quantifiable outcome

  • Simulation results aligned with experimental data for drug combination predictions

Companies that use Physiq

Customer profile

Ideal customer profiles1 record

Physiq technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Physiq partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights3 records

Physiq competitors and assessment

Company assessment

Broad incumbents

  • Preventice Solutions (Boston Scientific): Preventice, now part of Boston Scientific, offers BodyGuardian wearable cardiac monitors with cloud-based analytics, comparable to PhysIQ's continuous monitoring and AI analytics approach. Both target hospital systems and cardiology practices.
  • Medtronic: Medtronic offers a broad portfolio of patient monitoring, implanted sensors, and remote cardiac devices with integrated analytics. It is comparable as the scaled incumbent that PhysIQ's wearable biosensor platform would compete against for hospital contracts.
  • GE HealthCare: GE HealthCare provides patient monitoring solutions including wearable and bedside vital signs devices with central monitoring analytics. It is comparable as an established incumbent in clinical-grade continuous monitoring that targets the same hospital customer base as PhysIQ.
  • BioTelemetry (Philips): BioTelemetry, acquired by Philips, provides remote cardiac monitoring services and connected device infrastructure for ambulatory patients. It is comparable as a scaled incumbent in wearable biosensor-driven RPM with hospital-channel reach.
  • Dexcom: Dexcom manufactures continuous glucose monitoring wearable sensors with cloud-based data analytics. It is comparable as a scaled wearable biosensor company with proprietary sensor technology and AI-driven clinical insights.

Direct peers

  • iRhythm Technologies: iRhythm develops wearable cardiac monitoring patches (Zio) with AI-based arrhythmia detection, directly comparable to PhysIQ's wearable biosensor patient monitoring platform. Both target continuous ambulatory monitoring with proprietary analytics for clinical decision support.
  • Vivify Health: Vivify Health provides an RPM platform with connected devices and patient engagement tools for chronic care management. It is comparable to PhysIQ in combining wearable/connected biosensors with a software platform for clinical monitoring.
  • Current Health: Current Health offers an FDA-cleared continuous vital signs monitoring platform with a wearable device and AI analytics for hospital-at-home and post-acute care. It directly overlaps with PhysIQ's described wearable biosensor + AI monitoring business.

Emerging players

  • Tempus Labs: Tempus builds AI-driven precision medicine platforms integrating clinical and molecular data, including patient digital-twin-adjacent capabilities. It overlaps with PhysIQ's described computational modeling and digital twin work in cancer treatment.
  • Health Catalyst: Health Catalyst provides healthcare data and analytics infrastructure, including real-world clinical data platforms for providers and life sciences. It is comparable to PhysIQ's data integration and clinical analytics layer of the business.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights7 records

Customer concentration

Physiq social profiles

Digital presence

Physiq financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Physiq leadership team

Management profile

Number of profiles

Profiles7 records

Physiq funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Physiq M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Physiq

What does Physiq do?

Physiq develops and delivers a healthcare technology platform that uses proprietary artificial intelligence together with wearable biosensors to monitor patients, producing continuous physiological data and clinical insights for healthcare providers managing patients outside traditional clinical settings.

When was Physiq founded?

Physiq was founded in 2011. It employs 11 to 50 people.

Where is Physiq based?

Physiq is headquartered in Chicago, United States, in the North America region.

Who are Physiq's main competitors?

Broad incumbents on record are Preventice Solutions (Boston Scientific), Medtronic, GE HealthCare, BioTelemetry (Philips) and Dexcom. Direct peers are iRhythm Technologies, Vivify Health and Current Health. Emerging players are Tempus Labs and Health Catalyst.

Does Physiq have an API?

No public API is recorded for Physiq.

What industry is Physiq in?

Physiq's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpacephysIQ’s eVO2Max™ demonstrates breakout ability to estimate cardiopulmonary functional capacity from wearable sensor data during daily routine activityphysIQ announced eVO2Max, a wearable sensor-based biomarker estimating VO2 Max from 24-hour daily activity data. It showed a correlation of r=0.91 with CPET-measured VO2 Max across health statuses and ages. The method was presented at the 2022 American Heart Association Scientific Sessions.Business Wire BlogphysIQ Announces Collaboration with InCarda Therapeutics and Syneos Health to Accelerate Innovative Phase III Study in Patients with Atrial FibrillationphysIQ announced a collaboration with InCarda Therapeutics and Syneos Health to accelerate a Phase III study of orally inhaled flecainide for atrial fibrillation. The trial uses wearable sensors and FDA-cleared biomarkers to screen and enroll 400 patients across 100 sites. The company aims to bring a convenient treatment to patients who need it.Samsung Global NewsroomVirtual care meets clinical trials: How physIQ is modernizing medical researchphysIQ offers an AI-based remote monitoring solution for clinical trials, using Samsung devices to collect continuous biosensor data. The company notes 392,193 active studies worldwide, with 55% of terminated trials failing due to low participation. The virtual design aims to improve patient engagement and data quality.Business Wire BlogNew Executive Appointments Position physIQ for Further Strategic Growth and Market ExpansionphysIQ announced two executive appointments to support its growth trajectory: Chris Economos was promoted to senior vice president of corporate development, while Michael Petrarca joined as senior vice president and general manager of life sciences. Both executives will focus on driving revenue growth and expanding strategic partnerships for the digital medicine company. Petrarca brings over 30 years of life sciences experience from organizations including Pfizer, Medidata, and Clarivate.Purdue UniversityPurdue University and physIQ partner to develop a smartwatch-based algorithm to detect early signs of viral infections, including COVID-19Purdue University and physIQ have co-developed a viral detection algorithm for smartwatches, which will be commercialized by physIQ. The technology was validated through a study of 100 participants using Samsung Galaxy watches compared against FDA-cleared biosensors. This collaboration aims to expand physIQ's physiological monitoring applications for early detection of infections like COVID-19.National Center for Biotechnology InformationPersonalized Analytics and a Wearable Biosensor Platform for Early Detection of COVID-19 Decompensation (DeCODe): Protocol for the Development of the COVID-19 Decompensation IndexphysIQ, in collaboration with the National Institutes of Health, proposes a two-phase prospective study to develop and validate a COVID-19 decompensation index (CDI) using wearable biosensor data from patients at University of Illinois Health. The CDI will be a binary classifier with a minimum AUC of 0.75, requiring 1200 cases in phase II.HjfPhysIQ, Department of Defense, Duke University, and HJF Partner to Study COVID-19PhysIQ, Duke University and the Henry M. Jackson Foundation announced a collaboration to deploy PhysIQ's pinpointIQ platform in an 18-month clinical trial evaluating investigational products for early treatment and post-exposure prophylaxis of COVID-19. The study will use continuous physiological data from wearable biosensors and machine-learning analytics to characterize immune response and assess disease progression. Funding comes from JPEO-CBRND on behalf of the Office of the Assistant Secretary of Defense for Health Affairs.News-MedicalBiometric smartwatch data could accurately detect earliy signs of COVID-19Purdue researchers are studying whether continuous smartwatch data can detect early COVID-19 signs like elevated heart and breathing rates. The study will recruit up to 100 participants to test practicality, with data informing physIQ's new algorithms. Researchers plan to expand to high-risk individuals.BioWorldPhysiq begins development of AI-based COVID-19 early warning systemPhysiq Inc. received a contract from the NIH to develop an AI-based index for early warning of COVID-19 decline. The index, called the COVID-19 Decompensation Index, will run on Physiq's Accelerateiq platform, analyzing data from FDA-cleared wearables to create personalized baselines for positive patients.DAICWearable Sensors and AI App Used to Remotely Monitor Heart Failure Patients in NorthShore Health SystemNorthShore University HealthSystem, Carnegie Mellon University, and physIQ are collaborating on a multi-phase pilot project to remotely monitor heart failure patients using wearable biosensors and AI. The initiative aims to predict hospitalizations up to 10 days in advance, improve patient outcomes, and reduce readmission rates by integrating technology into clinical workflows.